Skip to content
Screener

Xencor XNCR Operating Cash Flow

Operating Cash Flow at other companies

Amgen logo
AmgenAMGN
$4B+75.5%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$813M-29.0%
Janux Therapeutics logo
Janux TherapeuticsJANX
$12.48M+152%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
-$33.52M-190%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
-$25.92M-142%
Immix Biopharma, Inc. logo
Immix Biopharma, Inc.IMMX
-$9.83M-483%

Other financials

Income statement

See full
Revenue$51.2M+17.5%
Operating income-$37.1M-11.7%
Net income-$21.7M+29.5%
EPS (diluted)-$0.29+29.3%

Balance sheet

See full
Cash & equivalents$44.7M+0.5%
Total debt$170.1M-20.1%
Total equity$503.2M-18.9%
Total assets$725.0M-17.6%

Cash flow

See full
CapEx$538.0K+40.5%
Free cash flow-$56.2M-52.9%

Valuation

See full
Market cap$1.55B+210%
Enterprise value$1.67B+150%
P/S14.7×+11.3×

Profitability

See full
Operating margin-205.8%-2,501pp
Net margin-155.6%+78.8pp
FCF margin-198.4%-1,485pp

Returns & leverage

See full
Return on equity-29.1%+0.2pp
Debt / equity0.3×0.0×
Current ratio6.4×+1.1×

Where this comes from

Reported directly by Xencor in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The source filing: Xencor’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:02 PM EDT
Fiscal quarter
Q4 FY2028
Calendar quarter
Q4 2028
Accession
0001326732-26-000056
Line itemSix Months Ended June 30, 2026Six Months Ended June 30, 2025
Accrued expenses1,4712,631
Operating lease, net(1,180)877
Other assets and liabilities, net(3,639)(6,287)
Net cash used in operating activities(123,286)(52,589)
Cash flows from investing activities
Purchase of marketable debt securities(72,679)(176,810)
Purchase of property and equipment(1,148)(1,827)
Proceeds from sales of marketable equity securities13,399

Item 1. Financial Statements

FAQ

What is Xencor's operating cash flow?
Xencor (XNCR) reported operating cash flow of -$55.66M in Q2 2026.
How has Xencor's operating cash flow changed year-over-year?
Xencor's operating cash flow decreased by 53.0% year-over-year, from -$36.37M to -$55.66M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

Ask your AI about Xencor's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude